AG˹ٷ

STOCK TITAN

[SCHEDULE 13G/A] Invivyd, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A
Rhea-AI Filing Summary

This Schedule 13G/A discloses that Maverick Capital, Ltd., Maverick Capital Management, LLC and Lee S. Ainslie III report beneficial ownership of 10,229,118 shares of Invivyd, Inc., representing 8.5% of the 119,961,445 outstanding shares reported as of May 1, 2025. The filing identifies the shares as held for Maverick clients across five funds: Maverick Fund USA, Ltd. (2,253,369), Maverick Fund II, Ltd. (2,210,410), Maverick Long Enhanced Fund, Ltd. (2,419,202), Maverick HP, L.P. (2,139,246) and Maverick Long Fund, Ltd. (1,206,891).

Each reporting person states shared voting and dispositive power over these shares and no sole voting or dispositive power. The document is filed as a Schedule 13G (Amendment No. 2) and includes a certification that the securities were not acquired to change or influence control of the issuer. The filing lists Maverick's Dallas, TX address and Mr. Ainslie's West Palm Beach, FL address and is signed on 08/14/2025.

Questo Schedule 13G/A indica che Maverick Capital, Ltd., Maverick Capital Management, LLC e Lee S. Ainslie III dichiarano la titolarità effettiva di 10,229,118 azioni di Invivyd, Inc., pari al 8,5% delle 119,961,445 azioni in circolazione segnalate al 1 maggio 2025. La comunicazione identifica le azioni come detenute per clienti di Maverick in cinque fondi: Maverick Fund USA, Ltd. (2,253,369), Maverick Fund II, Ltd. (2,210,410), Maverick Long Enhanced Fund, Ltd. (2,419,202), Maverick HP, L.P. (2,139,246) e Maverick Long Fund, Ltd. (1,206,891).

Ogni soggetto segnalante dichiara di avere potere di voto e di disposizione condivisi su queste azioni e di non detenere potere di voto o di disposizione esclusivo. Il documento è depositato come Schedule 13G (Emendamento n. 2) e contiene una certificazione che i titoli non sono stati acquisiti con l'intento di modificare o influenzare il controllo dell'emittente. La segnalazione indica l'indirizzo di Maverick a Dallas, TX e quello del sig. Ainslie a West Palm Beach, FL ed è firmata il 08/14/2025.

Este Schedule 13G/A revela que Maverick Capital, Ltd., Maverick Capital Management, LLC y Lee S. Ainslie III declaran la titularidad beneficiaria de 10,229,118 acciones de Invivyd, Inc., que representan el 8,5% de las 119,961,445 acciones en circulación reportadas al 1 de mayo de 2025. La presentación identifica las acciones como mantenidas para clientes de Maverick en cinco fondos: Maverick Fund USA, Ltd. (2,253,369), Maverick Fund II, Ltd. (2,210,410), Maverick Long Enhanced Fund, Ltd. (2,419,202), Maverick HP, L.P. (2,139,246) y Maverick Long Fund, Ltd. (1,206,891).

Cada persona informante declara tener poder de voto y de disposición compartidos sobre estas acciones y no tener poder de voto ni de disposición exclusivo. El documento se presenta como Schedule 13G (Enmienda n.º 2) e incluye una certificación de que los valores no fueron adquiridos para cambiar o influir en el control del emisor. La presentación indica la dirección de Maverick en Dallas, TX y la del Sr. Ainslie en West Palm Beach, FL y está firmada el 08/14/2025.

� Schedule 13G/A� Maverick Capital, Ltd., Maverick Capital Management, LLC � Lee S. Ainslie III가 Invivyd, Inc.� 10,229,118�� 실질적으� 보유하고 있으�, 이는 2025� 5� 1� 기준 보고� � 119,961,445�� � 8.5%� 해당한다� 밝힙니다. 제출서류� 해당 주식� Maverick 고객� 위한 다섯 � 펀드에 보유� 것으� 구분합니�: Maverick Fund USA, Ltd. (2,253,369), Maverick Fund II, Ltd. (2,210,410), Maverick Long Enhanced Fund, Ltd. (2,419,202), Maverick HP, L.P. (2,139,246) � Maverick Long Fund, Ltd. (1,206,891).

� 보고자는 � 주식들에 대� 공동 의결� � 처분�� 보유하고 있으� 단독 의결권이� 처분권은 보유하지 않음� 명시합니�. 문서� Schedule 13G (수정� �2�)� 제출되었�, 해당 증권� 발행인의 지배권� 변경하거나 영향력을 행사하기 위해 취득� 것이 아님� 확인하는 인증� 포함합니�. 제출서에� Maverick� Dallas, TX 주소와 Ainslie 씨의 West Palm Beach, FL 주소가 기재되어 있으� 08/14/2025� 서명되었습니�.

Ce Schedule 13G/A révèle que Maverick Capital, Ltd., Maverick Capital Management, LLC et Lee S. Ainslie III déclarent la propriété bénéficiaire de 10,229,118 actions d'Invivyd, Inc., représentant 8,5% des 119,961,445 actions en circulation déclarées au 1er mai 2025. Le dépôt identifie ces actions comme détenues pour des clients de Maverick répartis sur cinq fonds : Maverick Fund USA, Ltd. (2,253,369), Maverick Fund II, Ltd. (2,210,410), Maverick Long Enhanced Fund, Ltd. (2,419,202), Maverick HP, L.P. (2,139,246) et Maverick Long Fund, Ltd. (1,206,891).

Chaque personne déclarant indique détenir des pouvoirs de vote et de disposition partagés sur ces actions et aucun pouvoir de vote ou de disposition exclusif. Le document est déposé en tant que Schedule 13G (Amendement n°2) et inclut une certification selon laquelle les titres n'ont pas été acquis afin de modifier ou d'influencer le contrôle de l'émetteur. Le dépôt mentionne l'adresse de Maverick à Dallas, TX et celle de M. Ainslie à West Palm Beach, FL, et est signé le 08/14/2025.

Dieses Schedule 13G/A legt offen, dass Maverick Capital, Ltd., Maverick Capital Management, LLC und Lee S. Ainslie III wirtschaftliches Eigentum an 10,229,118 Aktien von Invivyd, Inc. melden, was 8,5% der am 1. Mai 2025 gemeldeten 119,961,445 ausstehenden Aktien entspricht. Die Einreichung führt die Aktien als für Maverick-Kunden in fünf Fonds gehalten auf: Maverick Fund USA, Ltd. (2,253,369), Maverick Fund II, Ltd. (2,210,410), Maverick Long Enhanced Fund, Ltd. (2,419,202), Maverick HP, L.P. (2,139,246) und Maverick Long Fund, Ltd. (1,206,891).

Jede meldende Person gibt an, über diese Aktien gemeinsame Stimm- und Verfügungsbefugnis zu haben und keine alleinige Stimm- oder Verfügungsbefugnis. Das Dokument wird als Schedule 13G (Änderung Nr. 2) eingereicht und enthält eine Bestätigung, dass die Wertpapiere nicht zum Zweck der Änderung oder Beeinflussung der Kontrolle des Emittenten erworben wurden. In der Einreichung sind Mavericks Adresse in Dallas, TX und die Adresse von Herrn Ainslie in West Palm Beach, FL angegeben; unterzeichnet ist sie am 08/14/2025.

Positive
  • Beneficial ownership reported: 10,229,118 shares of Invivyd, representing 8.5% of outstanding stock.
  • Detailed fund-level disclosure: Shares are itemized across five Maverick funds with specific share counts.
Negative
  • None.

Insights

TL;DR: Maverick reports a material passive stake of 8.5% (10.23M shares) in Invivyd; ownership is held across five funds.

The Schedule 13G/A shows a material stake above the 5% reporting threshold: 10,229,118 shares or 8.5% of the 119,961,445 shares outstanding as of May 1, 2025. The filing attributes the shares to specific Maverick funds with share-level breakdowns, and reports only shared voting and dispositive power, not sole control. Because this is a 13G filing (Amendment No. 2) and includes a certification that the holdings were not acquired to influence control, the position should be interpreted as a significant passive economic interest rather than an activist or control-oriented stake.

TL;DR: Reporting structure indicates collective advisory control but no unilateral authority; certification denies takeover intent.

The filing names three reporting persons—Maverick Capital, Maverick Capital Management and Lee S. Ainslie III—and records shared voting and dispositive power of 10,229,118 shares while showing 0 sole voting or dispositive power. The use of Schedule 13G (rather than 13D) and the explicit certification in Item 10 signal that the holders are reporting as passive investors. From a governance perspective, the absence of sole power limits their ability to unilaterally influence board composition or corporate actions based solely on this disclosure.

Questo Schedule 13G/A indica che Maverick Capital, Ltd., Maverick Capital Management, LLC e Lee S. Ainslie III dichiarano la titolarità effettiva di 10,229,118 azioni di Invivyd, Inc., pari al 8,5% delle 119,961,445 azioni in circolazione segnalate al 1 maggio 2025. La comunicazione identifica le azioni come detenute per clienti di Maverick in cinque fondi: Maverick Fund USA, Ltd. (2,253,369), Maverick Fund II, Ltd. (2,210,410), Maverick Long Enhanced Fund, Ltd. (2,419,202), Maverick HP, L.P. (2,139,246) e Maverick Long Fund, Ltd. (1,206,891).

Ogni soggetto segnalante dichiara di avere potere di voto e di disposizione condivisi su queste azioni e di non detenere potere di voto o di disposizione esclusivo. Il documento è depositato come Schedule 13G (Emendamento n. 2) e contiene una certificazione che i titoli non sono stati acquisiti con l'intento di modificare o influenzare il controllo dell'emittente. La segnalazione indica l'indirizzo di Maverick a Dallas, TX e quello del sig. Ainslie a West Palm Beach, FL ed è firmata il 08/14/2025.

Este Schedule 13G/A revela que Maverick Capital, Ltd., Maverick Capital Management, LLC y Lee S. Ainslie III declaran la titularidad beneficiaria de 10,229,118 acciones de Invivyd, Inc., que representan el 8,5% de las 119,961,445 acciones en circulación reportadas al 1 de mayo de 2025. La presentación identifica las acciones como mantenidas para clientes de Maverick en cinco fondos: Maverick Fund USA, Ltd. (2,253,369), Maverick Fund II, Ltd. (2,210,410), Maverick Long Enhanced Fund, Ltd. (2,419,202), Maverick HP, L.P. (2,139,246) y Maverick Long Fund, Ltd. (1,206,891).

Cada persona informante declara tener poder de voto y de disposición compartidos sobre estas acciones y no tener poder de voto ni de disposición exclusivo. El documento se presenta como Schedule 13G (Enmienda n.º 2) e incluye una certificación de que los valores no fueron adquiridos para cambiar o influir en el control del emisor. La presentación indica la dirección de Maverick en Dallas, TX y la del Sr. Ainslie en West Palm Beach, FL y está firmada el 08/14/2025.

� Schedule 13G/A� Maverick Capital, Ltd., Maverick Capital Management, LLC � Lee S. Ainslie III가 Invivyd, Inc.� 10,229,118�� 실질적으� 보유하고 있으�, 이는 2025� 5� 1� 기준 보고� � 119,961,445�� � 8.5%� 해당한다� 밝힙니다. 제출서류� 해당 주식� Maverick 고객� 위한 다섯 � 펀드에 보유� 것으� 구분합니�: Maverick Fund USA, Ltd. (2,253,369), Maverick Fund II, Ltd. (2,210,410), Maverick Long Enhanced Fund, Ltd. (2,419,202), Maverick HP, L.P. (2,139,246) � Maverick Long Fund, Ltd. (1,206,891).

� 보고자는 � 주식들에 대� 공동 의결� � 처분�� 보유하고 있으� 단독 의결권이� 처분권은 보유하지 않음� 명시합니�. 문서� Schedule 13G (수정� �2�)� 제출되었�, 해당 증권� 발행인의 지배권� 변경하거나 영향력을 행사하기 위해 취득� 것이 아님� 확인하는 인증� 포함합니�. 제출서에� Maverick� Dallas, TX 주소와 Ainslie 씨의 West Palm Beach, FL 주소가 기재되어 있으� 08/14/2025� 서명되었습니�.

Ce Schedule 13G/A révèle que Maverick Capital, Ltd., Maverick Capital Management, LLC et Lee S. Ainslie III déclarent la propriété bénéficiaire de 10,229,118 actions d'Invivyd, Inc., représentant 8,5% des 119,961,445 actions en circulation déclarées au 1er mai 2025. Le dépôt identifie ces actions comme détenues pour des clients de Maverick répartis sur cinq fonds : Maverick Fund USA, Ltd. (2,253,369), Maverick Fund II, Ltd. (2,210,410), Maverick Long Enhanced Fund, Ltd. (2,419,202), Maverick HP, L.P. (2,139,246) et Maverick Long Fund, Ltd. (1,206,891).

Chaque personne déclarant indique détenir des pouvoirs de vote et de disposition partagés sur ces actions et aucun pouvoir de vote ou de disposition exclusif. Le document est déposé en tant que Schedule 13G (Amendement n°2) et inclut une certification selon laquelle les titres n'ont pas été acquis afin de modifier ou d'influencer le contrôle de l'émetteur. Le dépôt mentionne l'adresse de Maverick à Dallas, TX et celle de M. Ainslie à West Palm Beach, FL, et est signé le 08/14/2025.

Dieses Schedule 13G/A legt offen, dass Maverick Capital, Ltd., Maverick Capital Management, LLC und Lee S. Ainslie III wirtschaftliches Eigentum an 10,229,118 Aktien von Invivyd, Inc. melden, was 8,5% der am 1. Mai 2025 gemeldeten 119,961,445 ausstehenden Aktien entspricht. Die Einreichung führt die Aktien als für Maverick-Kunden in fünf Fonds gehalten auf: Maverick Fund USA, Ltd. (2,253,369), Maverick Fund II, Ltd. (2,210,410), Maverick Long Enhanced Fund, Ltd. (2,419,202), Maverick HP, L.P. (2,139,246) und Maverick Long Fund, Ltd. (1,206,891).

Jede meldende Person gibt an, über diese Aktien gemeinsame Stimm- und Verfügungsbefugnis zu haben und keine alleinige Stimm- oder Verfügungsbefugnis. Das Dokument wird als Schedule 13G (Änderung Nr. 2) eingereicht und enthält eine Bestätigung, dass die Wertpapiere nicht zum Zweck der Änderung oder Beeinflussung der Kontrolle des Emittenten erworben wurden. In der Einreichung sind Mavericks Adresse in Dallas, TX und die Adresse von Herrn Ainslie in West Palm Beach, FL angegeben; unterzeichnet ist sie am 08/14/2025.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Maverick Capital, Ltd.
Signature:/s/ Trevor Wiessmann*
Name/Title:By: Maverick Capital Management, LLC, its General Partner By: Lee S. Ainslie III, Manager
Date:08/14/2025
Maverick Capital Management, LLC
Signature:/s/ Trevor Wiessmann*
Name/Title:Lee S. Ainslie III, Manager
Date:08/14/2025
Lee S. Ainslie III
Signature:/s/ Trevor Wiessmann*
Name/Title:Lee S. Ainslie III, Manager
Date:08/14/2025

Comments accompanying signature: Under Power of Attorney, dated March 15, 2018

FAQ

What stake does Maverick report in Invivyd (IVVD)?

The filing reports beneficial ownership of 10,229,118 shares, representing 8.5% of Invivyd's outstanding common stock.

Who filed the Schedule 13G/A for IVVD?

The filing was made on behalf of Maverick Capital, Ltd., Maverick Capital Management, LLC and Lee S. Ainslie III.

Are these shares held with sole or shared voting power?

The reporting persons state 0 shares of sole voting or dispositive power and 10,229,118 shares of shared voting and dispositive power.

Is this an activist filing (Schedule 13D) or passive (Schedule 13G)?

This is filed as a Schedule 13G (Amendment No. 2), indicating the position is reported under passive-investor rules and not as an activist 13D filing.

On what outstanding-share base is the 8.5% calculated?

The percentage is based on 119,961,445 outstanding shares of common stock reported by the issuer as of May 1, 2025.

When was the filing signed?

The Schedule 13G/A signatures are dated 08/14/2025 (signed under a Power of Attorney dated March 15, 2018).
Invivyd

NASDAQ:IVVD

IVVD Rankings

IVVD Latest News

IVVD Latest SEC Filings

IVVD Stock Data

93.61M
69.63M
41.18%
66.14%
3.72%
Biotechnology
Biological Products, (no Disgnostic Substances)
United States
WALTHAM